Intriguingly, we found YAP was capable to promote ATR/Chk1 signaling via MCM6 in GC cells under 5-FU administration (Figure 6I), corroborating that MCM6 is a critical downstream target of YAP in GC. Here, CHEK1 is linked to gastric cancer.